(Q53398985)

13 May 2018

title

Abnormal expression of MDM2 in prostate carcinoma. (English)

1 reference

13 May 2018

author

Katia R. Leite

1

1 reference

13 May 2018

author name string

M F Franco

2

1 reference

13 May 2018

M Srougi

3

1 reference

13 May 2018

L J Nesrallah

4

1 reference

13 May 2018

A Nesrallah

5

1 reference

13 May 2018

R G Bevilacqua

6

1 reference

13 May 2018

E Darini

7

1 reference

13 May 2018

C M Carvalho

8

1 reference

13 May 2018

M I Meirelles

9

1 reference

13 May 2018

I Santana

10

1 reference

13 May 2018

L H Camara-Lopes

11

1 reference

13 May 2018

publication date

1 May 2001

1 reference

13 May 2018

published in

Modern Pathology

1 reference

13 May 2018

volume

14

1 reference

13 May 2018

page(s)

428-436

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

https://scigraph.springernature.com/pub.10.1038/modpathol.3880330

exact match

0 references

cites work

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Functions of the MDM2 oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Mdm-2: "big brother" of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Amplification of a gene encoding a p53-associated protein in human sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

MDM2 amplification, P53 mutation, and accumulation of the P53 gene product in malignant fibrous histiocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

The clinical significance of p53 aberrations in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Histologic grading of prostate cancer: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

p53 in prostate cancer: frequent expressed transition mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Clinical implications of the p53 tumor-suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

Interaction between the retinoblastoma protein and the oncoprotein MDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

p53-independent role of MDM2 in TGF-beta1 resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

A matter of life and cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

MDM2 amplification and loss of heterozygosity at Rb and p53 genes: no simultaneous alterations in the oncogenesis of liposarcomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

p53 and MDM2 alterations in osteosarcomas: correlation with clinicopathologic features and proliferative rate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

Overexpression of MDM2 in acute childhood lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

Strong correlation of basement membrane degradation with p53 inactivation and/or MDM2 overexpression in superficial urothelial carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

Immunohistochemical Mdm2 expression in minor salivary gland tumours and its relationship to p53 gene status

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

Fast and sensitive silver staining of DNA in polyacrylamide gels

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

Combined analysis with Bcl-2 and P53 immunostaining predicts poorer prognosis in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

p53 oncogene mutations in human prostate cancer specimens

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

Abnormal p53 expression is rare in clinically localized human prostate cancer: comparison between immunohistochemical and molecular detection of p53 mutations

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

Abnormal expression of MDM-2 in breast carcinomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880330

7 January 2021

10.1038/MODPATHOL.3880330

Identifiers

DOI

1 reference

13 May 2018

PubMed ID

11353053

1 reference

13 May 2018